nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—Cytochrome P450 3A4 Inhibitors—Cyclosporine—rheumatoid arthritis	0.406	1	CiPCiCtD
Aprepitant—colon cancer—Betamethasone—rheumatoid arthritis	0.127	0.366	CpDpCtD
Aprepitant—colon cancer—Dexamethasone—rheumatoid arthritis	0.127	0.366	CpDpCtD
Aprepitant—breast cancer—Dexamethasone—rheumatoid arthritis	0.0467	0.134	CpDpCtD
Aprepitant—breast cancer—Betamethasone—rheumatoid arthritis	0.0467	0.134	CpDpCtD
Aprepitant—CYP1A2—Leflunomide—rheumatoid arthritis	0.0116	0.072	CbGbCtD
Aprepitant—CYP2C9—Leflunomide—rheumatoid arthritis	0.0104	0.0649	CbGbCtD
Aprepitant—CYP3A7—Hydrocortisone—rheumatoid arthritis	0.0103	0.064	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Hydrocortisone—rheumatoid arthritis	0.0103	0.064	CbGbCtD
Aprepitant—CYP3A7—Cyclosporine—rheumatoid arthritis	0.00971	0.0604	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Cyclosporine—rheumatoid arthritis	0.00971	0.0604	CbGbCtD
Aprepitant—CYP3A5—Sulfasalazine—rheumatoid arthritis	0.00961	0.0598	CbGbCtD
Aprepitant—CYP3A5—Hydrocortisone—rheumatoid arthritis	0.00771	0.048	CbGbCtD
Aprepitant—CYP3A5—Cyclosporine—rheumatoid arthritis	0.00728	0.0453	CbGbCtD
Aprepitant—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.00671	0.0417	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Dexamethasone—rheumatoid arthritis	0.00639	0.0398	CbGbCtD
Aprepitant—CYP3A7—Dexamethasone—rheumatoid arthritis	0.00639	0.0398	CbGbCtD
Aprepitant—CYP2C19—Prednisone—rheumatoid arthritis	0.0062	0.0386	CbGbCtD
Aprepitant—CYP2C19—Cyclosporine—rheumatoid arthritis	0.00587	0.0366	CbGbCtD
Aprepitant—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.00494	0.0308	CbGbCtD
Aprepitant—CYP2C9—Cyclosporine—rheumatoid arthritis	0.00488	0.0304	CbGbCtD
Aprepitant—CYP3A5—Dexamethasone—rheumatoid arthritis	0.0048	0.0298	CbGbCtD
Aprepitant—CYP2C19—Dexamethasone—rheumatoid arthritis	0.00387	0.0241	CbGbCtD
Aprepitant—CYP3A4—Triamcinolone—rheumatoid arthritis	0.00375	0.0233	CbGbCtD
Aprepitant—CYP2C9—Dexamethasone—rheumatoid arthritis	0.00322	0.02	CbGbCtD
Aprepitant—CYP3A4—Betamethasone—rheumatoid arthritis	0.00321	0.02	CbGbCtD
Aprepitant—CYP3A4—Prednisolone—rheumatoid arthritis	0.00317	0.0197	CbGbCtD
Aprepitant—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.00301	0.0187	CbGbCtD
Aprepitant—CYP3A4—Prednisone—rheumatoid arthritis	0.003	0.0186	CbGbCtD
Aprepitant—CYP3A4—Cyclosporine—rheumatoid arthritis	0.00284	0.0177	CbGbCtD
Aprepitant—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00187	0.0116	CbGbCtD
Aprepitant—Discomfort—Dexamethasone—rheumatoid arthritis	3.3e-05	0.00057	CcSEcCtD
Aprepitant—Discomfort—Betamethasone—rheumatoid arthritis	3.3e-05	0.00057	CcSEcCtD
Aprepitant—Dyspepsia—Hydrocortisone—rheumatoid arthritis	3.3e-05	0.00057	CcSEcCtD
Aprepitant—Hypotension—Methylprednisolone—rheumatoid arthritis	3.29e-05	0.000568	CcSEcCtD
Aprepitant—Pain—Prednisolone—rheumatoid arthritis	3.28e-05	0.000567	CcSEcCtD
Aprepitant—Decreased appetite—Hydrocortisone—rheumatoid arthritis	3.26e-05	0.000563	CcSEcCtD
Aprepitant—Pharyngitis—Methotrexate—rheumatoid arthritis	3.25e-05	0.000562	CcSEcCtD
Aprepitant—Nausea—Leflunomide—rheumatoid arthritis	3.24e-05	0.000561	CcSEcCtD
Aprepitant—Urinary tract disorder—Methotrexate—rheumatoid arthritis	3.24e-05	0.000559	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	3.23e-05	0.000559	CcSEcCtD
Aprepitant—Fatigue—Hydrocortisone—rheumatoid arthritis	3.23e-05	0.000558	CcSEcCtD
Aprepitant—Urethral disorder—Methotrexate—rheumatoid arthritis	3.21e-05	0.000555	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	3.21e-05	0.000555	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	3.21e-05	0.000554	CcSEcCtD
Aprepitant—Pain—Hydrocortisone—rheumatoid arthritis	3.2e-05	0.000553	CcSEcCtD
Aprepitant—Oedema—Betamethasone—rheumatoid arthritis	3.2e-05	0.000553	CcSEcCtD
Aprepitant—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	3.2e-05	0.000553	CcSEcCtD
Aprepitant—Anaphylactic shock—Betamethasone—rheumatoid arthritis	3.2e-05	0.000553	CcSEcCtD
Aprepitant—Oedema—Dexamethasone—rheumatoid arthritis	3.2e-05	0.000553	CcSEcCtD
Aprepitant—Insomnia—Triamcinolone—rheumatoid arthritis	3.19e-05	0.000551	CcSEcCtD
Aprepitant—Insomnia—Methylprednisolone—rheumatoid arthritis	3.18e-05	0.00055	CcSEcCtD
Aprepitant—Infection—Betamethasone—rheumatoid arthritis	3.18e-05	0.000549	CcSEcCtD
Aprepitant—Infection—Dexamethasone—rheumatoid arthritis	3.18e-05	0.000549	CcSEcCtD
Aprepitant—Ill-defined disorder—Prednisone—rheumatoid arthritis	3.17e-05	0.000547	CcSEcCtD
Aprepitant—Paraesthesia—Triamcinolone—rheumatoid arthritis	3.17e-05	0.000547	CcSEcCtD
Aprepitant—Feeling abnormal—Prednisolone—rheumatoid arthritis	3.16e-05	0.000546	CcSEcCtD
Aprepitant—Paraesthesia—Methylprednisolone—rheumatoid arthritis	3.16e-05	0.000546	CcSEcCtD
Aprepitant—Anaemia—Prednisone—rheumatoid arthritis	3.16e-05	0.000545	CcSEcCtD
Aprepitant—Shock—Dexamethasone—rheumatoid arthritis	3.15e-05	0.000544	CcSEcCtD
Aprepitant—Shock—Betamethasone—rheumatoid arthritis	3.15e-05	0.000544	CcSEcCtD
Aprepitant—Dyspnoea—Triamcinolone—rheumatoid arthritis	3.14e-05	0.000543	CcSEcCtD
Aprepitant—Nervous system disorder—Betamethasone—rheumatoid arthritis	3.14e-05	0.000542	CcSEcCtD
Aprepitant—Nervous system disorder—Dexamethasone—rheumatoid arthritis	3.14e-05	0.000542	CcSEcCtD
Aprepitant—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	3.13e-05	0.000541	CcSEcCtD
Aprepitant—Thrombocytopenia—Betamethasone—rheumatoid arthritis	3.13e-05	0.000541	CcSEcCtD
Aprepitant—Tachycardia—Betamethasone—rheumatoid arthritis	3.12e-05	0.00054	CcSEcCtD
Aprepitant—Tachycardia—Dexamethasone—rheumatoid arthritis	3.12e-05	0.00054	CcSEcCtD
Aprepitant—Angioedema—Prednisone—rheumatoid arthritis	3.12e-05	0.000539	CcSEcCtD
Aprepitant—Hypersensitivity—Cyclosporine—rheumatoid arthritis	3.1e-05	0.000537	CcSEcCtD
Aprepitant—Dyspepsia—Triamcinolone—rheumatoid arthritis	3.1e-05	0.000536	CcSEcCtD
Aprepitant—Erythema multiforme—Methotrexate—rheumatoid arthritis	3.1e-05	0.000536	CcSEcCtD
Aprepitant—Dyspepsia—Methylprednisolone—rheumatoid arthritis	3.1e-05	0.000535	CcSEcCtD
Aprepitant—Hyperhidrosis—Betamethasone—rheumatoid arthritis	3.09e-05	0.000535	CcSEcCtD
Aprepitant—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	3.09e-05	0.000535	CcSEcCtD
Aprepitant—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	3.09e-05	0.000533	CcSEcCtD
Aprepitant—Malaise—Prednisone—rheumatoid arthritis	3.08e-05	0.000532	CcSEcCtD
Aprepitant—Eye disorder—Methotrexate—rheumatoid arthritis	3.06e-05	0.000529	CcSEcCtD
Aprepitant—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	3.06e-05	0.000529	CcSEcCtD
Aprepitant—Syncope—Prednisone—rheumatoid arthritis	3.06e-05	0.000529	CcSEcCtD
Aprepitant—Tinnitus—Methotrexate—rheumatoid arthritis	3.06e-05	0.000528	CcSEcCtD
Aprepitant—Anorexia—Betamethasone—rheumatoid arthritis	3.05e-05	0.000527	CcSEcCtD
Aprepitant—Anorexia—Dexamethasone—rheumatoid arthritis	3.05e-05	0.000527	CcSEcCtD
Aprepitant—Urticaria—Prednisolone—rheumatoid arthritis	3.05e-05	0.000526	CcSEcCtD
Aprepitant—Cardiac disorder—Methotrexate—rheumatoid arthritis	3.04e-05	0.000526	CcSEcCtD
Aprepitant—Fatigue—Triamcinolone—rheumatoid arthritis	3.04e-05	0.000525	CcSEcCtD
Aprepitant—Fatigue—Methylprednisolone—rheumatoid arthritis	3.03e-05	0.000524	CcSEcCtD
Aprepitant—Asthenia—Cyclosporine—rheumatoid arthritis	3.02e-05	0.000523	CcSEcCtD
Aprepitant—Pain—Triamcinolone—rheumatoid arthritis	3.02e-05	0.000521	CcSEcCtD
Aprepitant—Loss of consciousness—Prednisone—rheumatoid arthritis	3e-05	0.000519	CcSEcCtD
Aprepitant—Hypotension—Betamethasone—rheumatoid arthritis	2.99e-05	0.000517	CcSEcCtD
Aprepitant—Hypotension—Dexamethasone—rheumatoid arthritis	2.99e-05	0.000517	CcSEcCtD
Aprepitant—Pruritus—Cyclosporine—rheumatoid arthritis	2.98e-05	0.000515	CcSEcCtD
Aprepitant—Urticaria—Hydrocortisone—rheumatoid arthritis	2.98e-05	0.000514	CcSEcCtD
Aprepitant—Angiopathy—Methotrexate—rheumatoid arthritis	2.97e-05	0.000514	CcSEcCtD
Aprepitant—Immune system disorder—Methotrexate—rheumatoid arthritis	2.96e-05	0.000512	CcSEcCtD
Aprepitant—Body temperature increased—Hydrocortisone—rheumatoid arthritis	2.96e-05	0.000512	CcSEcCtD
Aprepitant—Abdominal pain—Hydrocortisone—rheumatoid arthritis	2.96e-05	0.000512	CcSEcCtD
Aprepitant—Convulsion—Prednisone—rheumatoid arthritis	2.96e-05	0.000511	CcSEcCtD
Aprepitant—Mediastinal disorder—Methotrexate—rheumatoid arthritis	2.95e-05	0.000511	CcSEcCtD
Aprepitant—Hypertension—Prednisone—rheumatoid arthritis	2.95e-05	0.000509	CcSEcCtD
Aprepitant—Chills—Methotrexate—rheumatoid arthritis	2.94e-05	0.000508	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	2.92e-05	0.000504	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	2.92e-05	0.000504	CcSEcCtD
Aprepitant—Arthralgia—Prednisone—rheumatoid arthritis	2.91e-05	0.000502	CcSEcCtD
Aprepitant—Myalgia—Prednisone—rheumatoid arthritis	2.91e-05	0.000502	CcSEcCtD
Aprepitant—Feeling abnormal—Triamcinolone—rheumatoid arthritis	2.91e-05	0.000502	CcSEcCtD
Aprepitant—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	2.9e-05	0.000501	CcSEcCtD
Aprepitant—Anxiety—Prednisone—rheumatoid arthritis	2.9e-05	0.000501	CcSEcCtD
Aprepitant—Alopecia—Methotrexate—rheumatoid arthritis	2.9e-05	0.000501	CcSEcCtD
Aprepitant—Insomnia—Betamethasone—rheumatoid arthritis	2.89e-05	0.0005	CcSEcCtD
Aprepitant—Insomnia—Dexamethasone—rheumatoid arthritis	2.89e-05	0.0005	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	2.89e-05	0.000499	CcSEcCtD
Aprepitant—Diarrhoea—Cyclosporine—rheumatoid arthritis	2.88e-05	0.000498	CcSEcCtD
Aprepitant—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	2.88e-05	0.000497	CcSEcCtD
Aprepitant—Paraesthesia—Dexamethasone—rheumatoid arthritis	2.87e-05	0.000497	CcSEcCtD
Aprepitant—Paraesthesia—Betamethasone—rheumatoid arthritis	2.87e-05	0.000497	CcSEcCtD
Aprepitant—Discomfort—Prednisone—rheumatoid arthritis	2.87e-05	0.000496	CcSEcCtD
Aprepitant—Mental disorder—Methotrexate—rheumatoid arthritis	2.87e-05	0.000496	CcSEcCtD
Aprepitant—Erythema—Methotrexate—rheumatoid arthritis	2.85e-05	0.000493	CcSEcCtD
Aprepitant—Malnutrition—Methotrexate—rheumatoid arthritis	2.85e-05	0.000493	CcSEcCtD
Aprepitant—Hypersensitivity—Prednisolone—rheumatoid arthritis	2.83e-05	0.000488	CcSEcCtD
Aprepitant—Dyspepsia—Betamethasone—rheumatoid arthritis	2.82e-05	0.000487	CcSEcCtD
Aprepitant—Dyspepsia—Dexamethasone—rheumatoid arthritis	2.82e-05	0.000487	CcSEcCtD
Aprepitant—Urticaria—Triamcinolone—rheumatoid arthritis	2.8e-05	0.000484	CcSEcCtD
Aprepitant—Urticaria—Methylprednisolone—rheumatoid arthritis	2.8e-05	0.000483	CcSEcCtD
Aprepitant—Dysgeusia—Methotrexate—rheumatoid arthritis	2.79e-05	0.000483	CcSEcCtD
Aprepitant—Body temperature increased—Triamcinolone—rheumatoid arthritis	2.79e-05	0.000482	CcSEcCtD
Aprepitant—Dizziness—Cyclosporine—rheumatoid arthritis	2.79e-05	0.000482	CcSEcCtD
Aprepitant—Oedema—Prednisone—rheumatoid arthritis	2.79e-05	0.000482	CcSEcCtD
Aprepitant—Anaphylactic shock—Prednisone—rheumatoid arthritis	2.79e-05	0.000482	CcSEcCtD
Aprepitant—Abdominal pain—Methylprednisolone—rheumatoid arthritis	2.78e-05	0.000481	CcSEcCtD
Aprepitant—Decreased appetite—Dexamethasone—rheumatoid arthritis	2.78e-05	0.000481	CcSEcCtD
Aprepitant—Decreased appetite—Betamethasone—rheumatoid arthritis	2.78e-05	0.000481	CcSEcCtD
Aprepitant—Infection—Prednisone—rheumatoid arthritis	2.77e-05	0.000478	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	2.76e-05	0.000477	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	2.76e-05	0.000477	CcSEcCtD
Aprepitant—Back pain—Methotrexate—rheumatoid arthritis	2.76e-05	0.000477	CcSEcCtD
Aprepitant—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	2.76e-05	0.000477	CcSEcCtD
Aprepitant—Fatigue—Dexamethasone—rheumatoid arthritis	2.76e-05	0.000477	CcSEcCtD
Aprepitant—Fatigue—Betamethasone—rheumatoid arthritis	2.76e-05	0.000477	CcSEcCtD
Aprepitant—Shock—Prednisone—rheumatoid arthritis	2.74e-05	0.000474	CcSEcCtD
Aprepitant—Pain—Betamethasone—rheumatoid arthritis	2.74e-05	0.000473	CcSEcCtD
Aprepitant—Pain—Dexamethasone—rheumatoid arthritis	2.74e-05	0.000473	CcSEcCtD
Aprepitant—Nervous system disorder—Prednisone—rheumatoid arthritis	2.73e-05	0.000472	CcSEcCtD
Aprepitant—Tachycardia—Prednisone—rheumatoid arthritis	2.72e-05	0.00047	CcSEcCtD
Aprepitant—Skin disorder—Prednisone—rheumatoid arthritis	2.71e-05	0.000468	CcSEcCtD
Aprepitant—Hyperhidrosis—Prednisone—rheumatoid arthritis	2.69e-05	0.000466	CcSEcCtD
Aprepitant—Asthenia—Hydrocortisone—rheumatoid arthritis	2.69e-05	0.000464	CcSEcCtD
Aprepitant—Vomiting—Cyclosporine—rheumatoid arthritis	2.68e-05	0.000463	CcSEcCtD
Aprepitant—Rash—Cyclosporine—rheumatoid arthritis	2.66e-05	0.000459	CcSEcCtD
Aprepitant—Anorexia—Prednisone—rheumatoid arthritis	2.66e-05	0.000459	CcSEcCtD
Aprepitant—Dermatitis—Cyclosporine—rheumatoid arthritis	2.65e-05	0.000459	CcSEcCtD
Aprepitant—Pruritus—Hydrocortisone—rheumatoid arthritis	2.65e-05	0.000458	CcSEcCtD
Aprepitant—Ill-defined disorder—Methotrexate—rheumatoid arthritis	2.65e-05	0.000458	CcSEcCtD
Aprepitant—Headache—Cyclosporine—rheumatoid arthritis	2.64e-05	0.000456	CcSEcCtD
Aprepitant—Anaemia—Methotrexate—rheumatoid arthritis	2.64e-05	0.000456	CcSEcCtD
Aprepitant—Feeling abnormal—Dexamethasone—rheumatoid arthritis	2.64e-05	0.000456	CcSEcCtD
Aprepitant—Feeling abnormal—Betamethasone—rheumatoid arthritis	2.64e-05	0.000456	CcSEcCtD
Aprepitant—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	2.62e-05	0.000452	CcSEcCtD
Aprepitant—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	2.62e-05	0.000452	CcSEcCtD
Aprepitant—Hypersensitivity—Triamcinolone—rheumatoid arthritis	2.6e-05	0.000449	CcSEcCtD
Aprepitant—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	2.59e-05	0.000448	CcSEcCtD
Aprepitant—Malaise—Methotrexate—rheumatoid arthritis	2.57e-05	0.000445	CcSEcCtD
Aprepitant—Diarrhoea—Hydrocortisone—rheumatoid arthritis	2.56e-05	0.000443	CcSEcCtD
Aprepitant—Urticaria—Betamethasone—rheumatoid arthritis	2.54e-05	0.000439	CcSEcCtD
Aprepitant—Urticaria—Dexamethasone—rheumatoid arthritis	2.54e-05	0.000439	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	2.54e-05	0.000439	CcSEcCtD
Aprepitant—Dizziness—Prednisolone—rheumatoid arthritis	2.54e-05	0.000438	CcSEcCtD
Aprepitant—Asthenia—Triamcinolone—rheumatoid arthritis	2.53e-05	0.000437	CcSEcCtD
Aprepitant—Body temperature increased—Betamethasone—rheumatoid arthritis	2.53e-05	0.000437	CcSEcCtD
Aprepitant—Abdominal pain—Betamethasone—rheumatoid arthritis	2.53e-05	0.000437	CcSEcCtD
Aprepitant—Abdominal pain—Dexamethasone—rheumatoid arthritis	2.53e-05	0.000437	CcSEcCtD
Aprepitant—Body temperature increased—Dexamethasone—rheumatoid arthritis	2.53e-05	0.000437	CcSEcCtD
Aprepitant—Asthenia—Methylprednisolone—rheumatoid arthritis	2.52e-05	0.000436	CcSEcCtD
Aprepitant—Insomnia—Prednisone—rheumatoid arthritis	2.52e-05	0.000436	CcSEcCtD
Aprepitant—Nausea—Cyclosporine—rheumatoid arthritis	2.5e-05	0.000433	CcSEcCtD
Aprepitant—Paraesthesia—Prednisone—rheumatoid arthritis	2.5e-05	0.000432	CcSEcCtD
Aprepitant—Pruritus—Triamcinolone—rheumatoid arthritis	2.49e-05	0.000431	CcSEcCtD
Aprepitant—Cough—Methotrexate—rheumatoid arthritis	2.49e-05	0.00043	CcSEcCtD
Aprepitant—Pruritus—Methylprednisolone—rheumatoid arthritis	2.49e-05	0.00043	CcSEcCtD
Aprepitant—Dizziness—Hydrocortisone—rheumatoid arthritis	2.48e-05	0.000428	CcSEcCtD
Aprepitant—Convulsion—Methotrexate—rheumatoid arthritis	2.47e-05	0.000427	CcSEcCtD
Aprepitant—Dyspepsia—Prednisone—rheumatoid arthritis	2.45e-05	0.000424	CcSEcCtD
Aprepitant—Chest pain—Methotrexate—rheumatoid arthritis	2.43e-05	0.00042	CcSEcCtD
Aprepitant—Myalgia—Methotrexate—rheumatoid arthritis	2.43e-05	0.00042	CcSEcCtD
Aprepitant—Arthralgia—Methotrexate—rheumatoid arthritis	2.43e-05	0.00042	CcSEcCtD
Aprepitant—Decreased appetite—Prednisone—rheumatoid arthritis	2.42e-05	0.000419	CcSEcCtD
Aprepitant—Rash—Prednisolone—rheumatoid arthritis	2.42e-05	0.000418	CcSEcCtD
Aprepitant—Dermatitis—Prednisolone—rheumatoid arthritis	2.42e-05	0.000417	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	2.41e-05	0.000417	CcSEcCtD
Aprepitant—Diarrhoea—Methylprednisolone—rheumatoid arthritis	2.41e-05	0.000416	CcSEcCtD
Aprepitant—Fatigue—Prednisone—rheumatoid arthritis	2.4e-05	0.000415	CcSEcCtD
Aprepitant—Headache—Prednisolone—rheumatoid arthritis	2.4e-05	0.000415	CcSEcCtD
Aprepitant—Discomfort—Methotrexate—rheumatoid arthritis	2.4e-05	0.000415	CcSEcCtD
Aprepitant—Constipation—Prednisone—rheumatoid arthritis	2.38e-05	0.000412	CcSEcCtD
Aprepitant—Vomiting—Hydrocortisone—rheumatoid arthritis	2.38e-05	0.000412	CcSEcCtD
Aprepitant—Rash—Hydrocortisone—rheumatoid arthritis	2.36e-05	0.000408	CcSEcCtD
Aprepitant—Dermatitis—Hydrocortisone—rheumatoid arthritis	2.36e-05	0.000408	CcSEcCtD
Aprepitant—Confusional state—Methotrexate—rheumatoid arthritis	2.35e-05	0.000406	CcSEcCtD
Aprepitant—Headache—Hydrocortisone—rheumatoid arthritis	2.35e-05	0.000405	CcSEcCtD
Aprepitant—Dizziness—Triamcinolone—rheumatoid arthritis	2.33e-05	0.000403	CcSEcCtD
Aprepitant—Anaphylactic shock—Methotrexate—rheumatoid arthritis	2.33e-05	0.000402	CcSEcCtD
Aprepitant—Dizziness—Methylprednisolone—rheumatoid arthritis	2.33e-05	0.000402	CcSEcCtD
Aprepitant—Infection—Methotrexate—rheumatoid arthritis	2.31e-05	0.0004	CcSEcCtD
Aprepitant—Feeling abnormal—Prednisone—rheumatoid arthritis	2.3e-05	0.000397	CcSEcCtD
Aprepitant—Asthenia—Betamethasone—rheumatoid arthritis	2.3e-05	0.000397	CcSEcCtD
Aprepitant—Asthenia—Dexamethasone—rheumatoid arthritis	2.3e-05	0.000397	CcSEcCtD
Aprepitant—Nervous system disorder—Methotrexate—rheumatoid arthritis	2.28e-05	0.000395	CcSEcCtD
Aprepitant—Thrombocytopenia—Methotrexate—rheumatoid arthritis	2.28e-05	0.000394	CcSEcCtD
Aprepitant—Gastrointestinal pain—Prednisone—rheumatoid arthritis	2.28e-05	0.000394	CcSEcCtD
Aprepitant—Nausea—Prednisolone—rheumatoid arthritis	2.28e-05	0.000394	CcSEcCtD
Aprepitant—Pruritus—Betamethasone—rheumatoid arthritis	2.26e-05	0.000391	CcSEcCtD
Aprepitant—Pruritus—Dexamethasone—rheumatoid arthritis	2.26e-05	0.000391	CcSEcCtD
Aprepitant—Skin disorder—Methotrexate—rheumatoid arthritis	2.26e-05	0.000391	CcSEcCtD
Aprepitant—Hyperhidrosis—Methotrexate—rheumatoid arthritis	2.25e-05	0.000389	CcSEcCtD
Aprepitant—Vomiting—Triamcinolone—rheumatoid arthritis	2.24e-05	0.000387	CcSEcCtD
Aprepitant—Vomiting—Methylprednisolone—rheumatoid arthritis	2.24e-05	0.000387	CcSEcCtD
Aprepitant—Nausea—Hydrocortisone—rheumatoid arthritis	2.22e-05	0.000384	CcSEcCtD
Aprepitant—Rash—Triamcinolone—rheumatoid arthritis	2.22e-05	0.000384	CcSEcCtD
Aprepitant—Dermatitis—Triamcinolone—rheumatoid arthritis	2.22e-05	0.000384	CcSEcCtD
Aprepitant—Anorexia—Methotrexate—rheumatoid arthritis	2.22e-05	0.000384	CcSEcCtD
Aprepitant—Rash—Methylprednisolone—rheumatoid arthritis	2.22e-05	0.000383	CcSEcCtD
Aprepitant—Dermatitis—Methylprednisolone—rheumatoid arthritis	2.22e-05	0.000383	CcSEcCtD
Aprepitant—Urticaria—Prednisone—rheumatoid arthritis	2.21e-05	0.000383	CcSEcCtD
Aprepitant—Headache—Triamcinolone—rheumatoid arthritis	2.21e-05	0.000382	CcSEcCtD
Aprepitant—Headache—Methylprednisolone—rheumatoid arthritis	2.2e-05	0.000381	CcSEcCtD
Aprepitant—Abdominal pain—Prednisone—rheumatoid arthritis	2.2e-05	0.000381	CcSEcCtD
Aprepitant—Body temperature increased—Prednisone—rheumatoid arthritis	2.2e-05	0.000381	CcSEcCtD
Aprepitant—Diarrhoea—Betamethasone—rheumatoid arthritis	2.19e-05	0.000378	CcSEcCtD
Aprepitant—Diarrhoea—Dexamethasone—rheumatoid arthritis	2.19e-05	0.000378	CcSEcCtD
Aprepitant—Hypotension—Methotrexate—rheumatoid arthritis	2.18e-05	0.000376	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	2.12e-05	0.000367	CcSEcCtD
Aprepitant—Dizziness—Dexamethasone—rheumatoid arthritis	2.12e-05	0.000366	CcSEcCtD
Aprepitant—Dizziness—Betamethasone—rheumatoid arthritis	2.12e-05	0.000366	CcSEcCtD
Aprepitant—Insomnia—Methotrexate—rheumatoid arthritis	2.11e-05	0.000364	CcSEcCtD
Aprepitant—Nausea—Triamcinolone—rheumatoid arthritis	2.09e-05	0.000362	CcSEcCtD
Aprepitant—Paraesthesia—Methotrexate—rheumatoid arthritis	2.09e-05	0.000361	CcSEcCtD
Aprepitant—Nausea—Methylprednisolone—rheumatoid arthritis	2.09e-05	0.000361	CcSEcCtD
Aprepitant—Dyspnoea—Methotrexate—rheumatoid arthritis	2.08e-05	0.000359	CcSEcCtD
Aprepitant—Somnolence—Methotrexate—rheumatoid arthritis	2.07e-05	0.000358	CcSEcCtD
Aprepitant—Hypersensitivity—Prednisone—rheumatoid arthritis	2.05e-05	0.000355	CcSEcCtD
Aprepitant—Dyspepsia—Methotrexate—rheumatoid arthritis	2.05e-05	0.000354	CcSEcCtD
Aprepitant—Vomiting—Betamethasone—rheumatoid arthritis	2.03e-05	0.000352	CcSEcCtD
Aprepitant—Vomiting—Dexamethasone—rheumatoid arthritis	2.03e-05	0.000352	CcSEcCtD
Aprepitant—Decreased appetite—Methotrexate—rheumatoid arthritis	2.02e-05	0.00035	CcSEcCtD
Aprepitant—Rash—Dexamethasone—rheumatoid arthritis	2.02e-05	0.000349	CcSEcCtD
Aprepitant—Rash—Betamethasone—rheumatoid arthritis	2.02e-05	0.000349	CcSEcCtD
Aprepitant—Dermatitis—Dexamethasone—rheumatoid arthritis	2.02e-05	0.000348	CcSEcCtD
Aprepitant—Dermatitis—Betamethasone—rheumatoid arthritis	2.02e-05	0.000348	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	2.01e-05	0.000347	CcSEcCtD
Aprepitant—Fatigue—Methotrexate—rheumatoid arthritis	2.01e-05	0.000347	CcSEcCtD
Aprepitant—Headache—Betamethasone—rheumatoid arthritis	2e-05	0.000346	CcSEcCtD
Aprepitant—Headache—Dexamethasone—rheumatoid arthritis	2e-05	0.000346	CcSEcCtD
Aprepitant—Asthenia—Prednisone—rheumatoid arthritis	2e-05	0.000346	CcSEcCtD
Aprepitant—Pain—Methotrexate—rheumatoid arthritis	1.99e-05	0.000344	CcSEcCtD
Aprepitant—Pruritus—Prednisone—rheumatoid arthritis	1.97e-05	0.000341	CcSEcCtD
Aprepitant—Feeling abnormal—Methotrexate—rheumatoid arthritis	1.92e-05	0.000332	CcSEcCtD
Aprepitant—Diarrhoea—Prednisone—rheumatoid arthritis	1.91e-05	0.00033	CcSEcCtD
Aprepitant—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	1.9e-05	0.000329	CcSEcCtD
Aprepitant—Nausea—Dexamethasone—rheumatoid arthritis	1.9e-05	0.000328	CcSEcCtD
Aprepitant—Nausea—Betamethasone—rheumatoid arthritis	1.9e-05	0.000328	CcSEcCtD
Aprepitant—Urticaria—Methotrexate—rheumatoid arthritis	1.85e-05	0.00032	CcSEcCtD
Aprepitant—Dizziness—Prednisone—rheumatoid arthritis	1.84e-05	0.000318	CcSEcCtD
Aprepitant—Body temperature increased—Methotrexate—rheumatoid arthritis	1.84e-05	0.000318	CcSEcCtD
Aprepitant—Abdominal pain—Methotrexate—rheumatoid arthritis	1.84e-05	0.000318	CcSEcCtD
Aprepitant—Vomiting—Prednisone—rheumatoid arthritis	1.77e-05	0.000306	CcSEcCtD
Aprepitant—Rash—Prednisone—rheumatoid arthritis	1.76e-05	0.000304	CcSEcCtD
Aprepitant—Dermatitis—Prednisone—rheumatoid arthritis	1.76e-05	0.000303	CcSEcCtD
Aprepitant—Headache—Prednisone—rheumatoid arthritis	1.75e-05	0.000302	CcSEcCtD
Aprepitant—Hypersensitivity—Methotrexate—rheumatoid arthritis	1.72e-05	0.000297	CcSEcCtD
Aprepitant—Asthenia—Methotrexate—rheumatoid arthritis	1.67e-05	0.000289	CcSEcCtD
Aprepitant—Nausea—Prednisone—rheumatoid arthritis	1.66e-05	0.000286	CcSEcCtD
Aprepitant—Pruritus—Methotrexate—rheumatoid arthritis	1.65e-05	0.000285	CcSEcCtD
Aprepitant—TACR3—Signaling by GPCR—IL2—rheumatoid arthritis	1.64e-05	0.000587	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—C3—rheumatoid arthritis	1.64e-05	0.000586	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—C5—rheumatoid arthritis	1.64e-05	0.000585	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CXCL8—rheumatoid arthritis	1.63e-05	0.000584	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—MMP3—rheumatoid arthritis	1.63e-05	0.000583	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—rheumatoid arthritis	1.63e-05	0.000582	CbGpPWpGaD
Aprepitant—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	1.63e-05	0.000581	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NFATC1—rheumatoid arthritis	1.61e-05	0.000575	CbGpPWpGaD
Aprepitant—CYP3A7—Biological oxidations—POMC—rheumatoid arthritis	1.61e-05	0.000575	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—rheumatoid arthritis	1.6e-05	0.000573	CbGpPWpGaD
Aprepitant—Diarrhoea—Methotrexate—rheumatoid arthritis	1.59e-05	0.000275	CcSEcCtD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	1.59e-05	0.000568	CbGpPWpGaD
Aprepitant—CYP2C9—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	1.54e-05	0.000551	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CCL5—rheumatoid arthritis	1.54e-05	0.00055	CbGpPWpGaD
Aprepitant—Dizziness—Methotrexate—rheumatoid arthritis	1.54e-05	0.000266	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—CCR6—rheumatoid arthritis	1.54e-05	0.00055	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—CCR5—rheumatoid arthritis	1.53e-05	0.000546	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—LEP—rheumatoid arthritis	1.53e-05	0.000546	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CSF2—rheumatoid arthritis	1.52e-05	0.000542	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—IL2RA—rheumatoid arthritis	1.51e-05	0.000538	CbGpPWpGaD
Aprepitant—CYP1A2—Arachidonic acid metabolism—PTGS2—rheumatoid arthritis	1.5e-05	0.000536	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NCF2—rheumatoid arthritis	1.5e-05	0.000535	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—C3—rheumatoid arthritis	1.49e-05	0.000534	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—rheumatoid arthritis	1.49e-05	0.000533	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—rheumatoid arthritis	1.49e-05	0.000531	CbGpPWpGaD
Aprepitant—Vomiting—Methotrexate—rheumatoid arthritis	1.48e-05	0.000256	CcSEcCtD
Aprepitant—Rash—Methotrexate—rheumatoid arthritis	1.47e-05	0.000254	CcSEcCtD
Aprepitant—Dermatitis—Methotrexate—rheumatoid arthritis	1.47e-05	0.000254	CcSEcCtD
Aprepitant—Headache—Methotrexate—rheumatoid arthritis	1.46e-05	0.000252	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—SH2B3—rheumatoid arthritis	1.46e-05	0.000521	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TRAF6—rheumatoid arthritis	1.46e-05	0.000521	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—GZMB—rheumatoid arthritis	1.45e-05	0.000518	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	1.45e-05	0.000518	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—FN1—rheumatoid arthritis	1.44e-05	0.000515	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IL6ST—rheumatoid arthritis	1.43e-05	0.000513	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CXCL2—rheumatoid arthritis	1.41e-05	0.000503	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CCL3—rheumatoid arthritis	1.41e-05	0.000503	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	1.4e-05	0.000501	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	1.4e-05	0.000501	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—rheumatoid arthritis	1.39e-05	0.000498	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CCR5—rheumatoid arthritis	1.39e-05	0.000496	CbGpPWpGaD
Aprepitant—Nausea—Methotrexate—rheumatoid arthritis	1.38e-05	0.000239	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—CD80—rheumatoid arthritis	1.38e-05	0.000493	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—SAA1—rheumatoid arthritis	1.38e-05	0.000492	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—FADS2—rheumatoid arthritis	1.37e-05	0.00049	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL2RA—rheumatoid arthritis	1.37e-05	0.000489	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—C3—rheumatoid arthritis	1.36e-05	0.000485	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NCF1—rheumatoid arthritis	1.35e-05	0.000481	CbGpPWpGaD
Aprepitant—CYP1A2—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	1.32e-05	0.000471	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—POMC—rheumatoid arthritis	1.31e-05	0.000469	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	1.3e-05	0.000466	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CD28—rheumatoid arthritis	1.3e-05	0.000463	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CCL2—rheumatoid arthritis	1.28e-05	0.000459	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IL6R—rheumatoid arthritis	1.28e-05	0.000457	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	1.28e-05	0.000457	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	1.28e-05	0.000457	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PLD4—rheumatoid arthritis	1.27e-05	0.000452	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—rheumatoid arthritis	1.26e-05	0.000452	CbGpPWpGaD
Aprepitant—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	1.26e-05	0.000449	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	1.24e-05	0.000442	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ACAN—rheumatoid arthritis	1.22e-05	0.000437	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—UBE2D1—rheumatoid arthritis	1.22e-05	0.000436	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—BDKRB2—rheumatoid arthritis	1.2e-05	0.000427	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CXCL12—rheumatoid arthritis	1.2e-05	0.000427	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—POMC—rheumatoid arthritis	1.19e-05	0.000427	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	1.19e-05	0.000425	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL6ST—rheumatoid arthritis	1.19e-05	0.000424	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—ADRBK1—rheumatoid arthritis	1.18e-05	0.000423	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TYK2—rheumatoid arthritis	1.17e-05	0.000417	CbGpPWpGaD
Aprepitant—CYP3A5—Biological oxidations—POMC—rheumatoid arthritis	1.16e-05	0.000415	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—rheumatoid arthritis	1.16e-05	0.000415	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—SLC25A12—rheumatoid arthritis	1.15e-05	0.000411	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—NOS3—rheumatoid arthritis	1.14e-05	0.000409	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	1.14e-05	0.000409	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GC—rheumatoid arthritis	1.12e-05	0.0004	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTGES—rheumatoid arthritis	1.12e-05	0.0004	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—RASGRP1—rheumatoid arthritis	1.12e-05	0.000399	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—SYK—rheumatoid arthritis	1.11e-05	0.000397	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	1.09e-05	0.000391	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	1.09e-05	0.000391	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PRKCQ—rheumatoid arthritis	1.09e-05	0.00039	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—POMC—rheumatoid arthritis	1.08e-05	0.000388	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—rheumatoid arthritis	1.08e-05	0.000387	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—TNF—rheumatoid arthritis	1.08e-05	0.000387	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—STAT1—rheumatoid arthritis	1.07e-05	0.000383	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CCL2—rheumatoid arthritis	1.06e-05	0.000379	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—FADS2—rheumatoid arthritis	1.06e-05	0.000379	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL6R—rheumatoid arthritis	1.06e-05	0.000378	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CXCL10—rheumatoid arthritis	1.06e-05	0.000378	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	1.04e-05	0.000373	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PLB1—rheumatoid arthritis	1.04e-05	0.000372	CbGpPWpGaD
Aprepitant—CYP3A4—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	1.02e-05	0.000364	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	1.02e-05	0.000363	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CXCL8—rheumatoid arthritis	1.01e-05	0.000363	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IL2—rheumatoid arthritis	9.7e-06	0.000347	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—FADS2—rheumatoid arthritis	9.67e-06	0.000346	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—IL6—rheumatoid arthritis	9.65e-06	0.000345	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MMP3—rheumatoid arthritis	9.64e-06	0.000345	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—TYK2—rheumatoid arthritis	9.64e-06	0.000344	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PTK2—rheumatoid arthritis	9.28e-06	0.000332	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	9.24e-06	0.00033	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—MMP9—rheumatoid arthritis	9.18e-06	0.000328	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PLD4—rheumatoid arthritis	9.15e-06	0.000327	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—MED1—rheumatoid arthritis	9.12e-06	0.000326	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CCL5—rheumatoid arthritis	9.1e-06	0.000325	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—NFKB1—rheumatoid arthritis	9.08e-06	0.000325	CbGpPWpGaD
Aprepitant—CYP2C19—Biological oxidations—POMC—rheumatoid arthritis	8.99e-06	0.000321	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CSF2—rheumatoid arthritis	8.96e-06	0.00032	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—MAPK8—rheumatoid arthritis	8.93e-06	0.000319	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	8.91e-06	0.000319	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ACAN—rheumatoid arthritis	8.84e-06	0.000316	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—IL2—rheumatoid arthritis	8.83e-06	0.000316	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	8.81e-06	0.000315	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—B3GNT2—rheumatoid arthritis	8.48e-06	0.000303	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ACP5—rheumatoid arthritis	8.48e-06	0.000303	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—SPP1—rheumatoid arthritis	8.43e-06	0.000301	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CXCL8—rheumatoid arthritis	8.39e-06	0.0003	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—SLC25A12—rheumatoid arthritis	8.31e-06	0.000297	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—FADS2—rheumatoid arthritis	8.26e-06	0.000295	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—VEGFA—rheumatoid arthritis	8.24e-06	0.000295	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CCR5—rheumatoid arthritis	8.2e-06	0.000293	CbGpPWpGaD
Aprepitant—CYP2C9—Biological oxidations—POMC—rheumatoid arthritis	8.2e-06	0.000293	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GC—rheumatoid arthritis	8.08e-06	0.000289	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTGES—rheumatoid arthritis	8.08e-06	0.000289	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL2RA—rheumatoid arthritis	8.08e-06	0.000289	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	8.04e-06	0.000287	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL2—rheumatoid arthritis	8.02e-06	0.000287	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—C3—rheumatoid arthritis	8.01e-06	0.000286	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—BGN—rheumatoid arthritis	7.63e-06	0.000273	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TGFB1—rheumatoid arthritis	7.57e-06	0.00027	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PLB1—rheumatoid arthritis	7.52e-06	0.000269	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—LEP—rheumatoid arthritis	7.46e-06	0.000266	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PLD4—rheumatoid arthritis	7.08e-06	0.000253	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—FN1—rheumatoid arthritis	7.03e-06	0.000251	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ALOX5—rheumatoid arthritis	7.02e-06	0.000251	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL6ST—rheumatoid arthritis	7e-06	0.00025	CbGpPWpGaD
Aprepitant—CYP1A2—Biological oxidations—POMC—rheumatoid arthritis	7e-06	0.00025	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	6.87e-06	0.000245	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ACAN—rheumatoid arthritis	6.83e-06	0.000244	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CD80—rheumatoid arthritis	6.74e-06	0.000241	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—MED1—rheumatoid arthritis	6.59e-06	0.000235	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PLD4—rheumatoid arthritis	6.45e-06	0.000231	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SLC25A12—rheumatoid arthritis	6.42e-06	0.00023	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—POMC—rheumatoid arthritis	6.41e-06	0.000229	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—FADS2—rheumatoid arthritis	6.38e-06	0.000228	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CCL2—rheumatoid arthritis	6.27e-06	0.000224	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GC—rheumatoid arthritis	6.25e-06	0.000223	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTGES—rheumatoid arthritis	6.25e-06	0.000223	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL6R—rheumatoid arthritis	6.25e-06	0.000223	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ACAN—rheumatoid arthritis	6.23e-06	0.000223	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TP53—rheumatoid arthritis	6.23e-06	0.000223	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—B3GNT2—rheumatoid arthritis	6.13e-06	0.000219	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ACP5—rheumatoid arthritis	6.13e-06	0.000219	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SLC25A12—rheumatoid arthritis	5.86e-06	0.000209	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PLB1—rheumatoid arthritis	5.81e-06	0.000208	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ENO1—rheumatoid arthritis	5.73e-06	0.000205	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IL6—rheumatoid arthritis	5.7e-06	0.000204	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GC—rheumatoid arthritis	5.7e-06	0.000204	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTGES—rheumatoid arthritis	5.7e-06	0.000204	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TYK2—rheumatoid arthritis	5.69e-06	0.000203	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NOS3—rheumatoid arthritis	5.59e-06	0.0002	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—BGN—rheumatoid arthritis	5.52e-06	0.000197	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PLD4—rheumatoid arthritis	5.51e-06	0.000197	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—POMC—rheumatoid arthritis	5.41e-06	0.000193	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ACAN—rheumatoid arthritis	5.32e-06	0.00019	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PLB1—rheumatoid arthritis	5.3e-06	0.000189	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—MED1—rheumatoid arthritis	5.1e-06	0.000182	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ALOX5—rheumatoid arthritis	5.08e-06	0.000181	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SLC25A12—rheumatoid arthritis	5.01e-06	0.000179	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CXCL8—rheumatoid arthritis	4.96e-06	0.000177	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GC—rheumatoid arthritis	4.87e-06	0.000174	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTGES—rheumatoid arthritis	4.87e-06	0.000174	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—B3GNT2—rheumatoid arthritis	4.74e-06	0.000169	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ACP5—rheumatoid arthritis	4.74e-06	0.000169	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL2—rheumatoid arthritis	4.74e-06	0.000169	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL6—rheumatoid arthritis	4.71e-06	0.000168	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—MED1—rheumatoid arthritis	4.65e-06	0.000166	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PLB1—rheumatoid arthritis	4.53e-06	0.000162	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MMP9—rheumatoid arthritis	4.48e-06	0.00016	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NFKB1—rheumatoid arthritis	4.44e-06	0.000158	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MAPK8—rheumatoid arthritis	4.36e-06	0.000156	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—B3GNT2—rheumatoid arthritis	4.32e-06	0.000154	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ACP5—rheumatoid arthritis	4.32e-06	0.000154	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—BGN—rheumatoid arthritis	4.26e-06	0.000152	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	4.25e-06	0.000152	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ENO1—rheumatoid arthritis	4.14e-06	0.000148	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CAT—rheumatoid arthritis	4.12e-06	0.000147	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	4.11e-06	0.000147	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—VEGFA—rheumatoid arthritis	4.03e-06	0.000144	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—MED1—rheumatoid arthritis	3.97e-06	0.000142	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ALOX5—rheumatoid arthritis	3.92e-06	0.00014	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—BGN—rheumatoid arthritis	3.89e-06	0.000139	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	3.86e-06	0.000138	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GC—rheumatoid arthritis	3.76e-06	0.000134	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	3.76e-06	0.000134	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TGFB1—rheumatoid arthritis	3.69e-06	0.000132	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—B3GNT2—rheumatoid arthritis	3.69e-06	0.000132	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ACP5—rheumatoid arthritis	3.69e-06	0.000132	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALOX5—rheumatoid arthritis	3.58e-06	0.000128	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	3.49e-06	0.000125	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	3.45e-06	0.000123	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—MTHFR—rheumatoid arthritis	3.44e-06	0.000123	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—BGN—rheumatoid arthritis	3.32e-06	0.000119	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ENO1—rheumatoid arthritis	3.2e-06	0.000114	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	3.15e-06	0.000112	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	3.15e-06	0.000112	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—MED1—rheumatoid arthritis	3.06e-06	0.000109	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALOX5—rheumatoid arthritis	3.06e-06	0.000109	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TP53—rheumatoid arthritis	3.04e-06	0.000109	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CAT—rheumatoid arthritis	2.98e-06	0.000106	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	2.92e-06	0.000104	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.87e-06	0.000103	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	2.85e-06	0.000102	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	2.85e-06	0.000102	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL6—rheumatoid arthritis	2.78e-06	9.95e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.75e-06	9.84e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—POMC—rheumatoid arthritis	2.75e-06	9.83e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.69e-06	9.61e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—BGN—rheumatoid arthritis	2.56e-06	9.16e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.51e-06	8.97e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ALB—rheumatoid arthritis	2.51e-06	8.96e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ENO1—rheumatoid arthritis	2.49e-06	8.91e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—MTHFR—rheumatoid arthritis	2.49e-06	8.88e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.45e-06	8.76e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—NOS3—rheumatoid arthritis	2.4e-06	8.57e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	2.36e-06	8.43e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CAT—rheumatoid arthritis	2.3e-06	8.23e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTGS2—rheumatoid arthritis	2.19e-06	7.84e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.15e-06	7.67e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CAT—rheumatoid arthritis	2.1e-06	7.5e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—POMC—rheumatoid arthritis	1.99e-06	7.11e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	1.92e-06	6.88e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—MTHFR—rheumatoid arthritis	1.92e-06	6.87e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ALB—rheumatoid arthritis	1.81e-06	6.48e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CAT—rheumatoid arthritis	1.79e-06	6.41e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	1.75e-06	6.26e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—NOS3—rheumatoid arthritis	1.73e-06	6.2e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTGS2—rheumatoid arthritis	1.59e-06	5.67e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—POMC—rheumatoid arthritis	1.54e-06	5.49e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	1.5e-06	5.35e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—POMC—rheumatoid arthritis	1.4e-06	5.01e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ALB—rheumatoid arthritis	1.4e-06	5.01e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CAT—rheumatoid arthritis	1.38e-06	4.95e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NOS3—rheumatoid arthritis	1.34e-06	4.79e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALB—rheumatoid arthritis	1.28e-06	4.57e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTGS2—rheumatoid arthritis	1.23e-06	4.38e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	1.22e-06	4.37e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—POMC—rheumatoid arthritis	1.2e-06	4.28e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	1.16e-06	4.13e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	1.12e-06	3.99e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALB—rheumatoid arthritis	1.09e-06	3.9e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	1.04e-06	3.73e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	9.55e-07	3.41e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—POMC—rheumatoid arthritis	9.24e-07	3.3e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALB—rheumatoid arthritis	8.43e-07	3.01e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	8.06e-07	2.88e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	7.37e-07	2.63e-05	CbGpPWpGaD
